Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Plantago Major Leaf is a non-standardized plant allergenic extract used primarily in the diagnosis and treatment of type I hypersensitivity to broadleaf plantain pollen. It belongs to the class of allergenic biologicals used in immunotherapy.
Name
Plantago Major Leaf
Raw Name
PLANTAGO MAJOR LEAF
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
4
Variant Count
4
Last Verified
February 17, 2026
About Plantago Major Leaf
Plantago Major Leaf is a non-standardized plant allergenic extract used primarily in the diagnosis and treatment of type I hypersensitivity to broadleaf plantain pollen. It belongs to the class of allergenic biologicals used in immunotherapy.
Detailed information about Plantago Major Leaf
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Plantago Major Leaf.
Plantago Major Leaf, commonly known as Broadleaf Plantain, is a perennial plant that has been integrated into modern clinical practice as a non-standardized plant allergenic extract. Within the pharmacological landscape, it belongs to the class of drugs known as Non-Standardized Plant Allergenic Extracts [EPC]. These are biological products regulated by the FDA's Center for Biologics Evaluation and Research (CBER). Unlike standardized extracts, which have a defined potency (such as Bioequivalent Allergy Units), non-standardized extracts like Plantago Major are prepared based on weight-to-volume (w/v) ratios of the raw material to the extraction solvent.
In a clinical setting, Plantago Major Leaf extract is primarily utilized for two purposes: the diagnosis of allergic sensitivity via skin testing and the treatment of allergic rhinitis or asthma through allergen immunotherapy (hyposensitization). The extract contains the specific proteins and glycoproteins found in the plant's leaves and pollen that trigger immunoglobulin E (IgE)-mediated allergic reactions in sensitized individuals. Historically, Plantago Major has been used in traditional medicine for its anti-inflammatory properties, but its role in contemporary clinical pharmacology is strictly defined by its immunomodulatory effects when administered as an extract.
The mechanism of action for Plantago Major Leaf extract depends on its application. For diagnostic purposes, when the extract is introduced into the skin (via prick or intradermal methods), it cross-links specific IgE antibodies bound to the surface of mast cells. This cross-linking triggers mast cell degranulation, releasing histamine and other inflammatory mediators, which results in a 'wheal and flare' reaction. This reaction allows healthcare providers to confirm a patient's sensitivity to the allergen.
When used therapeutically in immunotherapy, the mechanism is more complex and involves the gradual desensitization of the immune system. Repeated exposure to increasing doses of the Plantago Major extract leads to a shift in the immune response from a Th2-dominated profile (which promotes IgE production and allergic inflammation) to a Th1-dominated profile. This shift is characterized by the production of 'blocking antibodies,' specifically IgG4. These IgG4 antibodies compete with IgE for binding sites on the allergen, effectively preventing the allergic cascade. Furthermore, immunotherapy induces the production of regulatory T cells (Tregs) and interleukin-10 (IL-10), which suppress the overall inflammatory response to the plantain allergen.
Unlike traditional small-molecule drugs, the pharmacokinetic profile of an allergenic extract like Plantago Major Leaf does not follow standard ADME (Absorption, Distribution, Metabolism, and Elimination) pathways through the bloodstream.
The primary FDA-approved indications for Plantago Major Leaf extract include:
Off-label, some clinicians may use highly diluted forms in experimental sublingual immunotherapy (SLIT) protocols, though this is less common for non-standardized extracts compared to standardized ones.
Plantago Major Leaf is typically available in the following forms:
> Important: Only your healthcare provider can determine if Plantago Major Leaf is right for your specific condition. The administration of allergenic extracts must be performed under the supervision of a physician prepared to treat systemic anaphylaxis.
Dosage for Plantago Major Leaf extract is highly individualized and must be determined by an allergy specialist based on the patient's sensitivity levels.
For skin prick testing, a single drop of the 1:10 or 1:20 w/v extract is applied to the skin, followed by a puncture. For intradermal testing, 0.02 mL of a significantly more dilute solution (e.g., 1:1000 w/v) is injected into the dermis.
Therapy is divided into two phases:
Plantago Major Leaf extract is generally considered safe for use in children, provided the dosage is carefully titrated. There is no specific age-based dosage; rather, the dose is determined by the child's individual sensitivity, similar to adults. However, children under the age of 5 may have difficulty cooperating with the injection schedule and reporting early symptoms of systemic reactions. Healthcare providers must exercise extreme caution in this population.
No specific dosage adjustments are required for patients with renal impairment, as the clearance of allergenic proteins is not primarily dependent on renal filtration. However, the patient's overall health should be stable before beginning immunotherapy.
No dosage adjustments are necessary for patients with hepatic impairment, as the extract does not undergo significant hepatic metabolism.
Elderly patients (over 65) should be evaluated for cardiovascular stability. If an elderly patient is taking beta-blockers for hypertension or heart disease, immunotherapy may be contraindicated due to the risk of refractory anaphylaxis.
Plantago Major Leaf extract is administered exclusively by healthcare professionals in a clinical setting. It is never self-administered by the patient at home.
If a dose in the build-up phase is missed, the next dose may need to be reduced or the previous dose repeated to maintain safety. If several doses are missed, the healthcare provider may need to restart the build-up phase from a lower concentration. Do not attempt to 'double up' on doses to make up for a missed appointment.
An 'overdose' in the context of allergenic extracts refers to the administration of a dose that exceeds the patient's current tolerance level. Signs of an overdose include:
In the event of an overdose/systemic reaction, epinephrine (adrenaline) is the first-line treatment. Emergency medical services must be contacted immediately if a reaction occurs outside the clinical setting.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or skip appointments without medical guidance.
Most patients receiving Plantago Major Leaf extract will experience local reactions at the site of injection. These are generally considered a normal part of the body's immune response to the allergen.
> Warning: Stop taking Plantago Major Leaf and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' side effects associated with the prolonged use of Plantago Major Leaf extract. The primary risk of long-term therapy is the cumulative risk of having a systemic reaction during the years of treatment. However, for most patients, the long-term benefit is a significant reduction in allergy symptoms and a decreased risk of developing asthma.
Plantago Major Leaf extract, like all allergenic extracts, carries an FDA-mandated warning regarding the risk of severe systemic reactions.
Summary of Warning:
Report any unusual symptoms to your healthcare provider immediately. Even a mild reaction after one dose can precede a more severe reaction after the next dose.
Plantago Major Leaf extract is a potent biological agent that modifies the immune system. It is not a standard medication and requires strict adherence to safety protocols. Patients must be aware that while the goal is to reduce allergy symptoms, the treatment itself involves introducing the very substance they are allergic to into their body.
No FDA black box warnings for Plantago Major Leaf. (Note: While allergenic extracts as a class carry heavy warnings often referred to as 'boxed' in clinical literature, they are technically classified as 'Warnings and Precautions' in the specific labeling for many non-standardized extracts. However, the clinical severity remains the same as a black box warning.)
While Plantago Major Leaf extract does not typically cause drowsiness, a severe systemic reaction or the administration of epinephrine to treat a reaction will impair the ability to drive or operate machinery. Patients should ensure they feel completely well before leaving the clinic.
Alcohol consumption should be avoided for several hours before and after an injection. Alcohol can increase blood flow to the skin and potentially accelerate the absorption of the allergen, increasing the risk of a systemic reaction.
Immunotherapy with Plantago Major Leaf is typically a long-term commitment. Stopping the treatment prematurely will likely result in the return of allergy symptoms. There is no 'withdrawal syndrome' associated with stopping allergenic extracts, but the 'tapering' in this context refers to the gradual increase in the interval between doses during the maintenance phase.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Plantago Major Leaf.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or depression.
Patients allergic to Plantago Major may also show cross-reactivity with other members of the Plantaginaceae family or certain grasses. This is due to shared protein structures (homologous allergens). Your allergist will use this information to create a balanced immunotherapy 'cocktail' if you are allergic to multiple substances.
> Important: Your healthcare provider will evaluate your complete medical history, including heart health and lung function, before prescribing Plantago Major Leaf.
Plantago Major Leaf extract is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm when administered to a pregnant woman.
It is not known whether the allergenic components of Plantago Major Leaf extract are excreted in human milk. However, because these are large protein molecules and are administered in very small quantities, it is highly unlikely that they would be absorbed intact by the nursing infant. The benefits of maternal allergy control usually outweigh the theoretical risks to the infant.
Immunotherapy is effective in children as young as 5 years old. It has been shown to not only reduce current symptoms but also to prevent the 'allergic march'—the progression from allergic rhinitis to asthma.
Patients over the age of 65 may be at higher risk for complications from immunotherapy.
There is no evidence that renal impairment affects the safety or efficacy of Plantago Major Leaf extract. However, patients with end-stage renal disease (ESRD) may have altered immune function, and the decision to proceed with immunotherapy should be made cautiously.
No specific adjustments are needed. The proteins in the extract are broken down by proteases throughout the body and are not dependent on the liver's cytochrome P450 system for clearance.
> Important: Special populations require individualized medical assessment and a careful weighing of the risks of a systemic reaction against the benefits of allergy relief.
Plantago Major Leaf extract works through Immunologic Desensitization. The extract contains several key allergens, most notably the protein Pla m 1. When injected subcutaneously, these antigens are taken up by dendritic cells (antigen-presenting cells). These cells travel to the lymph nodes and present the allergen to naive T-cells. In an allergic person, this normally leads to Th2 cell activation. However, the controlled, gradually increasing doses in immunotherapy favor the development of Regulatory T-cells (Tregs). These Tregs secrete IL-10 and TGF-beta, which inhibit the allergic response and signal B-cells to switch production from IgE to IgG4. IgG4 acts as a 'blocking antibody,' preventing the allergen from reaching the IgE on mast cells.
| Parameter | Value |
|---|---|
| Bioavailability | Low (systemic), High (local immune interaction) |
| Protein Binding | N/A (Proteins are degraded) |
| Half-life | Variable (Hours for proteins, weeks for immune effect) |
| Tmax | 30-60 minutes (for local absorption) |
| Metabolism | Proteolysis (Protease-mediated degradation) |
| Excretion | Renal (as small peptide fragments) |
Plantago Major Leaf is classified as a Non-Standardized Plant Allergenic Extract. It is grouped with other weed extracts like Ragweed (though Ragweed is often standardized) and English Plantain. These fall under the broader therapeutic category of Biological Response Modifiers.
Common questions about Plantago Major Leaf
Plantago Major Leaf extract is primarily used in the medical field for the diagnosis and treatment of allergies to Broadleaf Plantain. In diagnostic settings, it is used during skin prick testing to confirm if a patient has a specific IgE-mediated sensitivity to this plant's proteins. Therapeutically, it is used in allergen immunotherapy, commonly known as 'allergy shots,' to help the body build a tolerance to the allergen. This treatment is intended for patients with allergic rhinitis, conjunctivitis, or asthma who do not get sufficient relief from standard medications or allergen avoidance. It is a long-term treatment aimed at modifying the underlying immune response rather than just masking symptoms.
The most common side effects are local reactions at the site of the injection, which occur in nearly all patients at some point during therapy. These include redness, itching, and a small amount of swelling (a wheal) where the needle entered the skin. These reactions typically appear within minutes and resolve within a few hours without treatment. Some patients may also experience mild systemic symptoms like sneezing, a runny nose, or slight fatigue on the day of the injection. While these common side effects are usually bothersome rather than dangerous, any reaction larger than the palm of your hand should be reported to your doctor. Your healthcare provider may adjust your next dose based on the size and duration of these local reactions.
It is generally advised to avoid alcohol consumption on the day of your Plantago Major Leaf injection. Alcohol causes vasodilation, which is the widening of blood vessels, and can increase blood flow to the skin and tissues. This increased circulation may cause the injected allergen to be absorbed into your bloodstream more quickly than intended, which can significantly increase the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can mask some of the early warning signs of an allergic reaction, such as feeling flushed or dizzy. For maximum safety, wait at least 24 hours after your injection before consuming alcoholic beverages. Always discuss your lifestyle habits with your allergist before beginning a course of immunotherapy.
The safety of starting Plantago Major Leaf immunotherapy during pregnancy has not been established, and it is generally not recommended to begin this treatment while pregnant. This is because the risk of a severe systemic reaction (anaphylaxis) could lead to a dangerous drop in maternal blood pressure and oxygen levels, potentially harming the developing fetus. However, if a woman is already on a stable maintenance dose of immunotherapy and becomes pregnant, many allergists will choose to continue the treatment at that same dose, as the risk of a reaction is much lower once maintenance is reached. The decision is always made on an individual basis, weighing the benefits of controlling the mother's allergies against the potential risks. If you are undergoing immunotherapy and plan to become pregnant, you must discuss this with your healthcare provider immediately.
Plantago Major Leaf immunotherapy is not a quick-fix treatment and requires patience, as it takes time to retrain the immune system. Most patients do not see a significant improvement in their allergy symptoms during the initial 'build-up' phase, which usually lasts 3 to 6 months. Noticeable relief typically begins once the patient reaches their maintenance dose, which is the highest dose they can safely tolerate. Full clinical benefits are usually observed after 12 months of consistent treatment. To achieve long-lasting results that persist even after the injections are stopped, most experts recommend continuing the therapy for a total of 3 to 5 years. Your doctor will monitor your progress throughout this time to ensure the treatment is effective.
Yes, you can stop taking Plantago Major Leaf injections suddenly without experiencing physical withdrawal symptoms, as it is not an addictive substance. However, stopping the treatment before the recommended 3-to-5-year course is finished will likely result in the return of your allergy symptoms over time. Immunotherapy works by gradually changing your immune system's response, and if the process is interrupted too early, the 'tolerance' built up may fade. If you need to stop treatment due to side effects, financial concerns, or a change in your medical status, you should consult your allergist. They can help you decide if a different treatment approach is needed or if you can resume the injections at a later date.
If you miss a scheduled injection of Plantago Major Leaf, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to administer any form of treatment yourself. The safety of immunotherapy depends on a specific schedule; if too much time passes between doses, your sensitivity to the allergen may increase, making your previous dose level potentially dangerous. Depending on how many days or weeks have passed since your last shot, your doctor may need to repeat your last dose, reduce the dose slightly, or even restart the build-up phase from a lower concentration. Consistency is key to both the safety and the success of allergen immunotherapy.
There is no clinical evidence to suggest that Plantago Major Leaf extract causes weight gain. The extract consists of small amounts of proteins and glycoproteins that interact with the immune system locally and in the lymph nodes; it does not have the systemic metabolic effects associated with medications like oral corticosteroids or certain antidepressants. If you experience weight changes while undergoing immunotherapy, it is likely due to other factors such as lifestyle changes, other medications, or an unrelated medical condition. Always discuss significant changes in your weight or overall health with your primary care physician to determine the underlying cause.
Plantago Major Leaf can be taken alongside most common medications, but there are some very important exceptions. Medications known as beta-blockers, which are often prescribed for high blood pressure or heart conditions, can make immunotherapy much more dangerous because they interfere with the effectiveness of epinephrine, the emergency treatment for a severe allergic reaction. Additionally, ACE inhibitors and MAO inhibitors may also increase the risk or severity of a reaction. On the other hand, many patients continue to take their daily allergy medications, such as antihistamines or nasal steroids, while receiving immunotherapy. It is vital that you provide your allergist with a complete and updated list of every medication and supplement you take.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts like Plantago Major Leaf than it is for pills. These are biological products, and different manufacturers may produce their own versions of Broadleaf Plantain extract. While they all contain the same basic allergens from the plant, they are 'non-standardized,' meaning the exact potency can vary between different manufacturers' products. Therefore, extracts from different companies are not considered interchangeable. If your doctor switches you to an extract from a different manufacturer, they will typically restart the dosing at a lower level to ensure your safety. Most insurance plans cover these extracts as part of a specialized allergy treatment plan.